Cymbalta® Delayed-Release Capsule Launch

Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released, following FDA approval. Cymbalta® is one of the most widely prescribed treatments for depression, anxiety and other disorders. During the 180-day exclusivity period, multiple companies have received FDA approval to market duloxetine HCI in various strengths.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand-name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

Over the next 30 days, Carlisle Medical will be contacting physicians to inform them that the generic version of Cymbalta® (duloxetine HCI) is available.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com